Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Jun 24 2017

Malaria

Snapshot
  • A 25-year-old female student presents to the ER with a three day history of fever and headache with shaking chills. She recently returned from a trip to Nigeria to see her grandparents. Her temperature is 102°F (38.9°C), pulse is 94/min, respirations are 18/min, and blood pressure is 125/70 mmHg. Patient appears pale on physical exam with mild scleral icterus. Complete blood count is notable for a hematocrit of 30%. Total bilirubin was 2.5 mg/dL with direct bilirubin being 0.3mg/dL. Results of a peripheral blood smear are as shown on the right.
Introduction
  • Classification
    • protozoa
      • Plasmodia spp.
  • Pathogenesis
    • Plasmodia spp. have 2 hosts and multiple distinct forms during its complex life cycle 
      • infection results in lysis and agglutination of RBCs
        • rupture of RBCs correlates with fever spikes
        • lysis occurs in a synchronized fashion (all RBCs lyse at the same time)
      • 4 species of Plasmodium cause malaria
        • P. falciparum
          • most common and most deadly species
            • occasionally causes death within 24 hours of symptom onset
          • malignant tertian malaria
          • irregular fever spikes (36-48 hours)
          • cerebral malaria 
            • lysed RBCs occlude capillaries in brain
          • no hypnozoite stage
        • P. vivax and P. ovale
          • benign tertian malaria
          • 48 hour fever spikes
            • "tertian" because you count day 1 and day 3, although fevers are actually 48 hours apart
          • hypnozoite stage
        • P. malariae
          • quartan malaria
          • 72 hour fever spikes
          • recrudescence
            • symptoms recur from low levels of organisms in RBCs
          • no hypnozoite stage
    • Transmission
      • Anopheles mosquito 
  • Immunity
    • HbS heterozygote (sickle cell trait)
      • protection against P. falciparum
    • absence of Duffy (Fy) on RBC
      • protect against P. vivax
      • most common in people of African descent

 

Presentation
  • Malaria 
    • cyclic fever at 48-72 hour intervals
      • shaking chills
      • soaking sweats
    • anemia (hemolytic)
    • splenomegaly
      • typically after > 4 days of symptoms
    • agitation
    • hyperventilation
    • bleeding
    • history of exposure in malaria-endemic area
    • patients are often asymptomatic between attacks
  • Symptoms suggesting an alternate diagnosis include
    • rash
    • lymphadenopathy
    • neck stiffness
    • photophobia
  • Complications
    • cerebral malaria
    • severe hemolytic anemia
    • renal failure
    • acute tubular necrosis
    • noncardiogenic pulmonary edema
Evaluation
  • Blood smear
    • Giemsa- or Wright-stained thick and thin blood films
    • trophozoites and schizonts visualized within RBCs
    • diagnosis of strain is essential to guide treatment
  • Rapid antigenic tests
  • Normocytic, normochromic anemia on CBC
Differential
  • Babesiosis
  • Viral hemorrhagic fever
  • Meningitis
  • Typhoid fever
Treatment
  • Drugs
    • chloroquine
      • kills erythrocytic forms of all susceptible Plasmodia spp.
        • P. vivax, ovale, and malariae are sensitive
        • P. falciparum can be resistant
      • retinopathy associated with long-term use
      • pruritus in dark-skinned persons
    • primaquine
      • use for P. vivax/ovale to kill latent hypnozoites
      • test for G6PD deficiency
    • for chloroquine-resistant P. falciparum use
      • mefloquine
      • quinine (test for G6PD deficiency)
      • artemether
      • atavaquone-proguanil (Malarone)
      • pyrimethamine/sulfadoxine
        • pyrimethamine is a dihydrofolate reductase inhibitor also used in toxoplasmosis
    • for severe infections use IV quinidine
Prognosis, Prevention and Complications
  • Prevention
    • kill mosquitoes
    • bed nets
    • long-sleeved clothes
    • DEET or other repellent
    • chemical prophylaxis for travelers
      • daily prophylaxis: atovaquone-proguanil, doxycycline, primaquine
      • weekly prophylaxis : chloroquine, mefloquine
        • can be used by pregnant travelers
  • Complications
    • occasionally fatal within 24 hrs
    • may present as complications (see presentation)
    • especially in pregnancy, children, and travellers from non-endemic areas
 
Question
1 of 3
Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options